124 related articles for article (PubMed ID: 20653802)
21. Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression.
Ramasubbu R
J Psychiatry Neurosci; 1999 Jan; 24(1):45-50. PubMed ID: 9987207
[TBL] [Abstract][Full Text] [Related]
22. Treatment of depression in HIV-infected patients.
Cazzullo CL; Bessone E; Bertrando P; Pedrazzoli L; Cusini M
J Psychiatry Neurosci; 1998 Nov; 23(5):293-7. PubMed ID: 9846034
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for and correlates of poststroke depression following discontinuation of antidepressants.
Fiedorowicz JG; Takezawa K; Robinson RG
J Neuropsychiatry Clin Neurosci; 2007; 19(4):399-405. PubMed ID: 18070842
[TBL] [Abstract][Full Text] [Related]
24. Fluoxetine versus moclobemide: cross-comparison between the time courses of improvement.
Stassen HH; Angst J; Delini-Stula A
Pharmacopsychiatry; 1999 Mar; 32(2):56-60. PubMed ID: 10333163
[TBL] [Abstract][Full Text] [Related]
25. Post-stroke depression, antidepressant treatment and rehabilitation results. A case-control study.
Paolucci S; Antonucci G; Grasso MG; Morelli D; Troisi E; Coiro P; De Angelis D; Rizzi F; Bragoni M
Cerebrovasc Dis; 2001; 12(3):264-71. PubMed ID: 11641594
[TBL] [Abstract][Full Text] [Related]
26. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
Joyce PR; Mulder RT; McKenzie JM; Luty SE; Cloninger CR
Depress Anxiety; 2004; 19(3):180-6. PubMed ID: 15129420
[TBL] [Abstract][Full Text] [Related]
27. Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: a double-blind, placebo-controlled study.
Choi-Kwon S; Han SW; Kwon SU; Kang DW; Choi JM; Kim JS
Stroke; 2006 Jan; 37(1):156-61. PubMed ID: 16306470
[TBL] [Abstract][Full Text] [Related]
28. Treating depression in adolescents.
Harv Ment Health Lett; 2010 Jan; 26(7):7. PubMed ID: 20213935
[No Abstract] [Full Text] [Related]
29. Authors of TADS study reply to letter raising concerns.
March JS;
BMJ; 2005 Mar; 330(7493):730-1. PubMed ID: 15790648
[No Abstract] [Full Text] [Related]
30. [Observation on effect of Wuling Capsule in treating poststroke depression].
Xu B; Zhou WY; Zhang SJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Jul; 27(7):640-2. PubMed ID: 17717928
[TBL] [Abstract][Full Text] [Related]
31. Antidepressant-benzodiazepine combination therapy.
Furukawa T
Am J Psychiatry; 1999 Nov; 156(11):1840. PubMed ID: 10553764
[No Abstract] [Full Text] [Related]
32. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy.
Dam M; Tonin P; De Boni A; Pizzolato G; Casson S; Ermani M; Freo U; Piron L; Battistin L
Stroke; 1996 Jul; 27(7):1211-4. PubMed ID: 8685930
[TBL] [Abstract][Full Text] [Related]
33. "Wish bias" in antidepressant drug trials?
Barbui C; Cipriani A; Brambilla P; Hotopf M
J Clin Psychopharmacol; 2004 Apr; 24(2):126-30. PubMed ID: 15206658
[TBL] [Abstract][Full Text] [Related]
34. Fluoxetine improves the quality of life in patients with poststroke emotional disturbances.
Choi-Kwon S; Choi J; Kwon SU; Kang DW; Kim JS
Cerebrovasc Dis; 2008; 26(3):266-71. PubMed ID: 18648199
[TBL] [Abstract][Full Text] [Related]
35. European agency approves use of fluoxetine for children and teens.
Eaton L
BMJ; 2006 Jun; 332(7555):1407. PubMed ID: 16777864
[No Abstract] [Full Text] [Related]
36. Tailoring treatment to parental values: a comment on TADS.
Antonuccio D
Arch Gen Psychiatry; 2008 Jun; 65(6):723; author reply 723-4. PubMed ID: 18519830
[No Abstract] [Full Text] [Related]
37. The lack of a placebo effect in a trial of fluoxetine in the treatment of fibromyalgia.
Zijlstra TR; van de Laar MA
Am J Med; 2002 Nov; 113(7):614; author reply 614-5. PubMed ID: 12459412
[No Abstract] [Full Text] [Related]
38. Adding group psychotherapy to medication treatment in dysthymia: a randomized prospective pilot study.
Hellerstein DJ; Little SA; Samstag LW; Batchelder S; Muran JC; Fedak M; Kreditor D; Rosenthal RN; Winston A
J Psychother Pract Res; 2001; 10(2):93-103. PubMed ID: 11264333
[TBL] [Abstract][Full Text] [Related]
39. Fluoxetine and suicide rates: suicide and the economy.
Camargo CA; Bloch DA
PLoS Med; 2006 Nov; 3(11):e501; author reply e504. PubMed ID: 17132055
[No Abstract] [Full Text] [Related]
40. Efficacy of Fluoxetine for Post-Ischemic Stroke Depression in Tanzania.
Rice DR; Okeng'o K; Massawe E; Ismail S; Mworia NA; Chiwanga F; Kapina B; Wasserman M; Mateen FJ
J Stroke Cerebrovasc Dis; 2022 Jan; 31(1):106181. PubMed ID: 34740138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
